Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshifumi Kawamura

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Kaku Igaku. the Japanese Journal of Nuclear Medicine|June 13, 2002
[Estimation by static SPECT of the radioactivity remaining after the first dose of two-fractionated 123I-IMP administration: the rate of increase in cerebral blood flow by ARG and the rate of increase in SPECT count]Yoshifumi Kawamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|July 11, 2009
[Human protein factory: an infrastructure to convert the human transcriptome into the in vitro-expressed proteome of versatile utility]Yoshifumi Kawamura, Naoki Goshima, Nobuo Nomura
Annals of Nuclear Medicine|July 5, 2008
Usefulness of rate of increase in SPECT counts in one-day method of N-isopropyl-4-iodoamphetamine [123I] SPECT studies at rest and after acetazolamide challenge using a method for estimating time-dependent distribution at restYoshifumi Kawamura, Michio Ashizaki, Shoko Saida, et al.
Cancer Science|July 30, 2021
Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cellsYoshifumi Kawamura, Ken Saijo, Hiroo Imai, et al.
Biotechnology Letters|June 19, 2010
Introduction of amino acid residues at the N-terminus of the zeocin-resistance protein increases its expression in Saccharomyces cerevisiaeYohei Sugano, Yoshifumi Kawamura, Naoki Goshima, et al.
Cancer Science|December 4, 2020
LPIN1 downregulation enhances anticancer activity of the novel HDAC/PI3K dual inhibitor FK-A11Hiroo Imai, Ken Saijo, Sonoko Chikamatsu, et al.
Cancer Medicine|June 26, 2025
Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal CancerReio Ueta, Hiroo Imai, Ken Saijo, et al.
New Biotechnology|September 15, 2010
Development and evaluation of data-driven designed tags (DDTs) for controlling protein solubilityShuichi Hirose, Yoshifumi Kawamura, Masatoshi Mori, et al.
Nucleic Acids Research|December 6, 2011
HGPD: Human Gene and Protein Database, 2012 updateYukio Maruyama, Yoshifumi Kawamura, Tetsuo Nishikawa, et al.
Cancer Medicine|August 1, 2019
In Vitro and in Vivo antitumor activity and the mechanism of siphonodictyal B in human colon cancer cellsSonoko Chikamatsu, Ken Saijo, Hiroo Imai, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Kaku Igaku. the Japanese Journal of Nuclear Medicine|June 13, 2002
[Estimation by static SPECT of the radioactivity remaining after the first dose of two-fractionated 123I-IMP administration: the rate of increase in cerebral blood flow by ARG and the rate of increase in SPECT count]Yoshifumi Kawamura
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|July 11, 2009
[Human protein factory: an infrastructure to convert the human transcriptome into the in vitro-expressed proteome of versatile utility]Yoshifumi Kawamura, Naoki Goshima, Nobuo Nomura
Annals of Nuclear Medicine|July 5, 2008
Usefulness of rate of increase in SPECT counts in one-day method of N-isopropyl-4-iodoamphetamine [123I] SPECT studies at rest and after acetazolamide challenge using a method for estimating time-dependent distribution at restYoshifumi Kawamura, Michio Ashizaki, Shoko Saida, et al.
Cancer Science|July 30, 2021
Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cellsYoshifumi Kawamura, Ken Saijo, Hiroo Imai, et al.
Biotechnology Letters|June 19, 2010
Introduction of amino acid residues at the N-terminus of the zeocin-resistance protein increases its expression in Saccharomyces cerevisiaeYohei Sugano, Yoshifumi Kawamura, Naoki Goshima, et al.
Cancer Science|December 4, 2020
LPIN1 downregulation enhances anticancer activity of the novel HDAC/PI3K dual inhibitor FK-A11Hiroo Imai, Ken Saijo, Sonoko Chikamatsu, et al.
Cancer Medicine|June 26, 2025
Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal CancerReio Ueta, Hiroo Imai, Ken Saijo, et al.
New Biotechnology|September 15, 2010
Development and evaluation of data-driven designed tags (DDTs) for controlling protein solubilityShuichi Hirose, Yoshifumi Kawamura, Masatoshi Mori, et al.
Nucleic Acids Research|December 6, 2011
HGPD: Human Gene and Protein Database, 2012 updateYukio Maruyama, Yoshifumi Kawamura, Tetsuo Nishikawa, et al.
Cancer Medicine|August 1, 2019
In Vitro and in Vivo antitumor activity and the mechanism of siphonodictyal B in human colon cancer cellsSonoko Chikamatsu, Ken Saijo, Hiroo Imai, et al.
Pageof 5